CARLOS ANTONIO
SIMON VALLES
CATEDRÁTICO/A DE UNIVERSIDAD
![Foto de Juan Antonio](/img/nophoto.png)
Juan Antonio
García Velasco
Publikationen, an denen er mitarbeitet Juan Antonio García Velasco (52)
2022
2018
-
Personalized ovarian stimulation for assisted reproductive technology: study design considerations to move from hype to added value for patients
Fertility and Sterility, Vol. 109, Núm. 6, pp. 968-979
2015
-
Is endometrial receptivity transcriptomics affected in women with endometriosis? A pilot study
Reproductive BioMedicine Online, Vol. 31, Núm. 5, pp. 647-654
2014
-
Impact of final oocyte maturation using gonadotropin-releasing hormone agonist triggering and different luteal support protocols on endometrial gene expression
Fertility and Sterility, Vol. 101, Núm. 1
-
The impact of using the combined oral contraceptive pill for cycle scheduling on gene expression related to endometrial receptivity
Human Reproduction, Vol. 29, Núm. 6, pp. 1271-1278
2012
-
Follicular and endocrine profiles associated with different GnRH-antagonist regimens: A randomized controlled trial
Reproductive BioMedicine Online, Vol. 24, Núm. 2, pp. 153-162
2011
-
High-dose recombinant LH add-back strategy using high-dose GnRH antagonist is an innovative protocol compared with standard GnRH antagonist
Reproductive BioMedicine Online, Vol. 22, Núm. S1, pp. S52-S59
-
The effects of ergot and non-ergot-derived dopamine agonists in an experimental mouse model of endometriosis
Reproduction, Vol. 142, Núm. 5, pp. 745-755
2010
-
Identification and quantification of dopamine receptor 2 in human eutopic and ectopic endometrium: A novel molecular target for endometriosis therapy
Biology of Reproduction, Vol. 83, Núm. 5, pp. 866-873
-
Physiology and pathology of ovarian hyperstimulation syndrome
Seminars in Reproductive Medicine, Vol. 28, Núm. 6, pp. 448-457
-
Prevención del síndrome de hiperestimulación ovárica
Revista Iberoamericana de Fertilidad y Reproduccion Humana
-
Prevention of OHSS: Current strategies and new insights
Middle East Fertility Society Journal, Vol. 15, Núm. 4, pp. 223-230
-
The non-ergot derived dopamine agonist quinagolide in prevention of early ovarian hyperstimulation syndrome in IVF patients: A randomized, double-blind, placebo-controlled trial
Human Reproduction, Vol. 25, Núm. 4, pp. 995-1004
2009
-
Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenesis in experimentally induced endometriosis
Obstetrical and Gynecological Survey
-
Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenesis in experimentally induced endometriosis
Human Reproduction, Vol. 24, Núm. 5, pp. 1025-1035
-
Symposium: Update on prediction and management of OHSS: Prevention of OHSS - Dopamine agonists
Reproductive BioMedicine Online
2008
-
Clinical factors affecting endometrial receptiveness in oocyte donation cycles
Fertility and Sterility, Vol. 89, Núm. 3, pp. 491-501
-
Dysfunctional uterine bleeding
Non-Invasive Management of Gynecologic Disorders (CRC Press), pp. 63-68
-
Molecular mechanisms of implantation
Infertility and Assisted Reproduction (Cambridge University Press), pp. 46-52
-
Ovarian hyperstimulation syndrome
Infertility and Assisted Reproduction (Cambridge University Press), pp. 243-257